Caredx Inc (NASDAQ: CDNA): Is It A Buying Opportunity Again?

After Hours

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.

Stocks Info

CDNA belongs to the Healthcare sector of the NASDAQ while operating in the Diagnostics & Research industry. The current market capitalization of Caredx Inc is $761.15M. A total of 1.63 million shares were traded on the day, compared to an average of 1.62M shares.

In the most recent transaction, Novack Jeffrey Adam sold 2,688 shares of CDNA for 12.79 per share on Aug 05 ’25. After the transaction, the Secretary and General Counsel now owns 112,930 company shares. In a previous transaction on Aug 05 ’25, Jeffrey Adam Novack bought 2,688 shares at 12.60 per share.

Among the insiders who sold shares, Maag Peter disposed of 10,000 shares on Jul 07 ’25 at a per-share price of $18.58. This resulted in the Director holding 308,846 shares of CDNA after the transaction. In another insider transaction, Valantine Hannah sold 10,570 shares at $19.16 per share on Jun 18 ’25. Company shares held by the Director now total 38,994.

While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, CDNA has a high of $32.97 and a low of $10.96.

As of this writing, CDNA has an earnings estimate of $0.14 per share for the current quarter. EPS was calculated based on a consensus of 6.0 estimates, with a high estimate of $0.17 per share and a lower estimate of $0.12. The company reported an EPS of $0.14 in the last quarter

Balance Sheet Annually/Quarterly

An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. CDNA’s latest balance sheet shows that the firm has $348.49M in Cash & Short Term Investments as of fiscal 2021. There were $21.35M in debt and $77.30M in liabilities at the time. Its Book Value Per Share was $6.15, while its Total Shareholder’s Equity was $465.88M.

Analysts Opinion

There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock.

Related Posts

Park Telegraph
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.